Q1 2026 Holdings
Filed 2026-05-15 | 51 holdings | $653.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $67.9M | 415,269 | 10.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $63.9M | 2,872,695 | 9.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $62.8M | 921,607 | 9.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $38.7M | 685,182 | 5.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $37.2M | 62,809 | 5.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $35.4M | 638,161 | 5.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $30.0M | 325,175 | 4.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $30.0M | 1,652,972 | 4.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $25.8M | 140,719 | 3.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $25.7M | 401,719 | 3.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $22.3M | 6,349,563 | 3.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $20.2M | 864,986 | 3.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.3M | 2,948,090 | 2.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $16.1M | 1,113,045 | 2.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $14.0M | 1,280,439 | 2.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $12.5M | 596,495 | 1.9% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $11.7M | 1,208,568 | 1.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $10.9M | 550,408 | 1.7% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $9.4M | 296,408 | 1.4% |
| Caredx Inc(CDNA) | COM | 14167L103 | $9.2M | 531,870 | 1.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $8.6M | 242,560 | 1.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $8.0M | 1,514,504 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.2M | 213,601 | 1.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $7.1M | 41,520 | 1.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $7.0M | 229,763 | 1.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $6.8M | 230,453 | 1.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.2M | 1,391,382 | 1.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $6.1M | 1,613,430 | 0.9% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $4.5M | 234,582 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.0M | 51,345 | 0.5% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $2.9M | 59,985 | 0.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.8M | 84,631 | 0.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $2.7M | 33,640 | 0.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.4M | 18,117 | 0.4% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $2.2M | 508,846 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.1M | 32,195 | 0.3% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $1.9M | 1,482,797 | 0.3% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.9M | 39,605 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.7M | 19,614 | 0.3% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.5M | 1,010,510 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.3M | 246,093 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $936.8K | 201,890 | 0.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $935.4K | 1,787 | 0.1% |
| Humana Inc(HUM) | COM | 444859102 | $691.0K | 3,985 | 0.1% |
| Compass Pathways PLC ADR(CMPS) | SPONSORED ADS | 20451W101 | $639.4K | 115,616 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $605.6K | 104,410 | 0.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $487.7K | 108,865 | 0.1% |
| Inspire Medical Systems Inc(INSP) | COM | 457730109 | $452.5K | 8,772 | 0.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $440.5K | 24,500 | 0.1% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $305.9K | 188,807 | 0.0% |